Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-20-020742

Options or other derivatives

  • Director acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cermak Elizabeth Director 2020-10-02 Grant or award · Stock option (right to buy) +40,000 40,000 D: show line 1 in the form
Loading xslF345X03/rdgdoc.xml…